Literature DB >> 20010454

Central retinal vein occlusion in a young Chinese population: risk factors and associated morbidity and mortality.

Jane Zea-Chin Kuo1, Chi-Chun Lai, Frank Shih-Chang Ong, Chia-Pang Shih, Ling Yeung, Tun-Lu Chen, Kuan-Jen Chen, Wei-Chi Wu.   

Abstract

PURPOSE: The purpose of this study was to assess the risk factors for central retinal vein occlusion and associated morbidity and mortality in a Chinese population.
METHODS: The participants included patients with central retinal vein occlusion 40 years old and younger. Predisposing factors, mortality, and systemic complications were examined in this group.
RESULTS: Unilateral (n = 19) and bilateral (n = 3) central retinal vein occlusions were identified in a total of 22 patients (25 eyes), with a mean follow-up time of 37 months. Hypercholesterolemia (65%), hypertriglyceridemia (64%), and hyperhomocysteinemia (42%) were all identified as risk factors. Three patients (14%) developed stroke and 1 (5%) developed transient ischemic attacks during follow-up. Renal failure and pulmonary hypertension resulted in the death of two patients. The mean initial and final visual acuities (+ or - standard deviation) were 20/400 (+ or - 20/250) and 20/500 (+ or - 20/320), respectively, and treatments did not result in vision improvement (P = 0.57). The poor visual prognosis was likely due to macular edema in 7 eyes (28%), optic atrophy in 4 eyes (16%), and secondary glaucoma in 3 eyes (12%).
CONCLUSION: Morbidity and mortality are high in young Chinese patients with central retinal vein occlusion who may have associated serious complications including stroke, blindness, and death. Central retinal vein occlusion may serve as an initial clinical presentation of serious systemic diseases.

Entities:  

Mesh:

Year:  2010        PMID: 20010454      PMCID: PMC2952633          DOI: 10.1097/IAE.0b013e3181b9b3a0

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  44 in total

1.  Drug or drusen? Central retinal vein occlusion in a young healthy woman with disc drusen.

Authors:  M J Gallagher; L G Clearkin
Journal:  Eye (Lond)       Date:  2000-06       Impact factor: 3.775

2.  Intravitreal triamcinolone acetonide for the treatment of central retinal vein occlusion in young patients.

Authors:  Murat Karacorlu; Hakan Ozdemir; Serra Karacorlu
Journal:  Retina       Date:  2004-04       Impact factor: 4.256

Review 3.  CVD risk factors and ethnicity--a homogeneous relationship?

Authors:  Nita G Forouhi; Naveed Sattar
Journal:  Atheroscler Suppl       Date:  2006-02-24       Impact factor: 3.235

4.  Central retinal vascular occlusion associated with oral contraceptives.

Authors:  G C Stowe; Z N Zakov; D M Albert
Journal:  Am J Ophthalmol       Date:  1978-12       Impact factor: 5.258

5.  Cilioretinal artery occlusion in young adults with central retinal vein occlusion.

Authors:  H Schatz; A C Fong; H R McDonald; R N Johnson; L Joffe; C P Wilkinson; J J de Laey; L A Yannuzzi; R T Wendel; B C Joondeph
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

6.  MTHFR C677T mutation in central retinal vein occlusion: a case-control study in Chinese population.

Authors:  Wei Gao; Yu-Sheng Wang; Peng Zhang; Hai-Yan Wang
Journal:  Thromb Res       Date:  2007-08-23       Impact factor: 3.944

7.  Hyperhomocysteinemia and low plasma folate as risk factors for central retinal vein occlusion: a case-control study in a Chinese population.

Authors:  Wei Gao; Yu-Sheng Wang; Peng Zhang; Hai-Yan Wang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-15       Impact factor: 3.117

8.  Differentiation of ischemic from non-ischemic central retinal vein occlusion during the early acute phase.

Authors:  S S Hayreh; M R Klugman; M Beri; A E Kimura; P Podhajsky
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

9.  Intensive immunosuppression treatment for central retinal vein occlusion in a young adult: a case report.

Authors:  François Willermain; Kathrin Greiner; John V Forrester
Journal:  Ocul Immunol Inflamm       Date:  2002-06       Impact factor: 3.070

10.  Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion.

Authors:  Lorenzo Di Crecchio; Maurizio Battaglia Parodi; Giorgia Sanguinetti; Pierluigi Iacono; Giuseppe Ravalico
Journal:  Ophthalmology       Date:  2004-05       Impact factor: 12.079

View more
  11 in total

Review 1.  Associations of retinal artery occlusion and retinal vein occlusion to mortality, stroke, and myocardial infarction: a systematic review.

Authors:  S C Y Woo; G Y H Lip; P L Lip
Journal:  Eye (Lond)       Date:  2016-06-03       Impact factor: 3.775

2.  A longitudinal analysis of risk factors associated with central retinal vein occlusion.

Authors:  Maxwell S Stem; Nidhi Talwar; Grant M Comer; Joshua D Stein
Journal:  Ophthalmology       Date:  2012-11-20       Impact factor: 12.079

3.  Intravitreal homocysteine-thiolactone injection leads to the degeneration of multiple retinal cells, including photoreceptors.

Authors:  Han-Hsin Chang; David Pei-Cheng Lin; Ying-Shan Chen; Hsiang-Jui Liu; Wei Lin; Zih-Jay Tsao; Mei-Ching Teng; Bo-Yie Chen
Journal:  Mol Vis       Date:  2011-07-19       Impact factor: 2.367

4.  Intense exercise causing central retinal vein occlusion in a young patient: case report and review of the literature.

Authors:  Elad Moisseiev; Oded Sagiv; Moshe Lazar
Journal:  Case Rep Ophthalmol       Date:  2014-04-05

5.  Retinal artery and vein thrombotic occlusion during pregnancy: markers for familial thrombophilia and adverse pregnancy outcomes.

Authors:  Will S Kurtz; Charles J Glueck; Robert K Hutchins; Robert A Sisk; Ping Wang
Journal:  Clin Ophthalmol       Date:  2016-05-23

6.  Central Retinal Vein Occlusion in Younger Swedish Adults: Case Reports and Review of the Literature.

Authors:  Elisabeth Wittström
Journal:  Open Ophthalmol J       Date:  2017-05-22

7.  Ranibizumab for Macular Edema Secondary to Central and Branch Retinal Vein Occlusion in Patients Younger Than 50 Years of Age.

Authors:  Maurizio Battaglia Parodi; Francesco Romano; Alessandro Arrigo; Stefano Mercuri; Alessandro Franceschi; Francesco Bandello
Journal:  Biomed Res Int       Date:  2020-06-17       Impact factor: 3.411

8.  Central retinal venous occlusion in a child with hyperhomocysteinemia: A case report.

Authors:  Zhengfeng Liu; Xuemei Pan; Wenjun Jiang; Hongsheng Bi
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

9.  Combined Central Retinal Vein And Artery Occlusion In A Patient With Elevated Level Of Factor VIII: A Case Report.

Authors:  In Boem Chang; Jae Hyup Lee; Hyun Woong Kim
Journal:  Int Med Case Rep J       Date:  2019-10-07

10.  Thrombophilia and retinal vascular occlusion.

Authors:  Charles J Glueck; Robert K Hutchins; Joel Jurantee; Zia Khan; Ping Wang
Journal:  Clin Ophthalmol       Date:  2012-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.